Peter Mac has received more than $6.3 million in funding from the National Health and Medical Research Council's Investigator Grant scheme to support our highest-performing researchers.
A Peter Mac clinical trial has opened in Swan Hill for the first time, showing living in regional Victoria need not be a barrier to accessing the very latest in cancer care.
Peter Mac scientists hope to gain new insights into what drives lung cancer, and how it responds to treatment, thanks to support from Pfizer's Emerging Science Fund.
Peter Mac Clinical Haematologist Dr Katherine Cummins is the recipient of the Gunn Family Women in Haematology Fellowship, awarded by the Snowdome Foundation and Maddie Riewoldt’s Vision.
Peter Mac’s C-SMART trial continues to investigate whether daily use of a medicated nasal spray could be protect cancer patients from viral respiratory infections, including COVID-19.
Fruit flies are allowing researchers to gain new insights into cachexia, a muscle-wasting condition responsible for up to one-third of cancer-related deaths.